Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis (Q91136638)
Jump to navigation
Jump to search
scientific article published on 09 October 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis |
scientific article published on 09 October 2018 |
Statements
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis (English)
Takashi Kumada
Hidenori Toyoda
Toshifumi Tada
Masashi Hirooka
Toru Ishikawa
Koichi Takaguchi
Noritomo Shimada
Hironori Ochi
Akemi Tsutsui
Kojiro Michitaka
Kazuya Kariyama
Kazuhiro Nouso
Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Ei Itobayashi
Kunihiko Tsuji